Clover Biopharmaceuticals receives FDA clearance for RSV vaccine trial, expands respiratory disease research

Clover Biopharmaceuticals advances RSV vaccine research with FDA-approved SCB-1019 trials, targeting revaccination gaps and combination immunization strategies. Read More